Skip to Content

REV 25 mg (Revlimid 25 mg)

Generic Name: lenalidomide

Pill with imprint REV 25 mg is White, Capsule-shape and has been identified as Revlimid 25 mg. It is supplied by Celgene Corporation.

Revlimid is used in the treatment of multiple myeloma; follicular lymphoma; lymphoma; myelodysplastic diseases; mantle cell lymphoma and belongs to the drug classes miscellaneous antineoplastics, other immunosuppressants. Not for use in pregnancy. Revlimid 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for REV 25 mg

Revlimid 25 mg REV 25 mg

Revlimid

Generic Name
lenalidomide
Imprint
REV 25 mg
Strength
25 mg
Color
White
Size
22.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Miscellaneous antineoplastics, Other immunosuppressants
Pregnancy Category
X - Not for use in pregnancy
CSA Schedule
Not a controlled drug
Labeler / Supplier
Celgene Corporation
National Drug Code (NDC)
59572-0425
Inactive Ingredients
lactose anhydrous, microcrystalline cellulose, croscarmellose sodium, magnesium stearate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.